Skip to main content
    Q

    Quantum BioPharma Ltd. (QNTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.44
    -0.17 (-10.56%)

    Market Cap: $10.35M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Quantum BioPharma Ltd. (QNTM) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Quantum BioPharma are Quoin Pharmaceuticals Ltd DRC (QNRX), Tscan Therapeutics (TCRX) and Intensity Therapeutics, Inc. Common stock (INTS). By market cap, Quantum BioPharma ranks 8th of the 13 companies on this page; Quoin Pharmaceuticals Ltd DRC (QNRX) is the largest at $17.78M.

    Peer Comparison

    QNTM's ROIC of -150.1% is above the peer median of -390.3%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Quantum BioPharma (QNTM)$10.35MN/AN/A0.0%-150.1%0.0%0.00%
    Quoin Pharmaceuticals Ltd DRC (QNRX)$17.78MN/AN/A0.0%N/A0.0%0.00%
    Tscan Therapeutics Inc (TCRX)$10.89MN/A3.6x0.0%-129.7%-65.8%0.00%
    Intensity Therapeutics, Inc. Common stock (INTS)$10.17MN/AN/A0.0%N/A0.0%0.00%
    Marker Therapeutics Inc (MRKR)$14.51MN/A14.5x-245.5%N/A-51.0%0.00%
    Moleculin Biotech Inc (MBRX)$8.02MN/AN/A0.0%N/A0.0%0.00%
    GT Biopharma Inc (GTBP)$7.67MN/AN/A0.0%N/A0.0%0.00%
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)$9.90MN/A16.4x0.0%-72.3%-15.9%0.00%
    Tempest Therapeutics Inc (TPST)$7.64MN/AN/A0.0%-783.6%0.0%0.00%
    Chemomab Therapeutics Ltd DRC (CMMB)$12.31MN/AN/A0.0%N/A0.0%0.00%
    Neuphoria Therapeutics Inc (NEUP)$13.80MN/AN/A0.0%N/A0.0%0.00%
    Pluri Inc. (PLUR)$15.09MN/A8.7x0.0%-650.8%-15.8%0.00%
    Tvardi Therapeutics, Inc. (TVRD)$15.74MN/AN/A0.0%N/A0.0%0.00%
    Peer median$11.60MN/A11.6x0.0%-390.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Quantum BioPharma, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Quoin Pharmaceuticals Ltd DRC (QNRX)
    Quoin Pharmaceuticals Ltd (QNRX) is an innovative biotechnology firm dedicated to developing cutting-edge therapeutics for rare diseases...
    QNRX competitors
    Tscan Therapeutics Inc (TCRX)
    Tscan Therapeutics Inc (TCRX) is a pioneering clinical-stage biotechnology company specializing in precision oncology through its proprietary T cell receptor...
    TCRX competitors
    Intensity Therapeutics, Inc. Common stock (INTS)
    Intensity Therapeutics, Inc. is a pioneering biotechnology firm committed to revolutionizing cancer treatment through cutting-edge drug delivery systems.
    INTS competitors
    Marker Therapeutics Inc (MRKR)
    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based...
    MRKR competitors
    Moleculin Biotech Inc (MBRX)
    Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant...
    MBRX competitors
    GT Biopharma Inc (GTBP)
    GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its...
    GTBP competitors
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)
    CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human...
    Tempest Therapeutics Inc (TPST)
    Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated...
    TPST competitors
    Chemomab Therapeutics Ltd DRC (CMMB)
    Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases.
    CMMB competitors
    Neuphoria Therapeutics Inc (NEUP)
    Neuphoria Therapeutics Inc (Ticker: NEUP) is a groundbreaking biotechnology firm focused on revolutionizing mental health disorders treatment via psychedelic...
    NEUP competitors
    Pluri Inc. (PLUR)
    Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy...
    PLUR competitors
    Tvardi Therapeutics, Inc. (TVRD)
    Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet...
    TVRD competitors

    Frequently Asked Questions About QNTM

    Who are Quantum BioPharma's main competitors?

    The companies most similar to Quantum BioPharma include Quoin Pharmaceuticals Ltd DRC (QNRX), Tscan Therapeutics (TCRX), Intensity Therapeutics, Inc. Common stock (INTS), Marker Therapeutics (MRKR) and Moleculin Biotech (MBRX), listed from the closest match.

    Who is Quantum BioPharma's biggest competitor?

    Quoin Pharmaceuticals Ltd DRC (QNRX) is both the largest of the similar companies at $17.78M and the closest match by business profile, size, sector and industry.

    How does QNTM stock compare with its competitors?

    QNTM's net margin is 0.0% against a peer median of 0.0%.

    Which of Quantum BioPharma's competitors pays a higher dividend?

    Quantum BioPharma pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Quantum BioPharma bigger than its competitors?

    No. Quantum BioPharma is 8th by market cap among the 13 companies on this page; the largest is Quoin Pharmaceuticals Ltd DRC (QNRX) at $17.78M.